CYTEK BIOSCIENCES, INC. Increase (Decrease) in Accounts Receivable
CYTEK BIOSCIENCES, INC. (CTKB) reported Increase (Decrease) in Accounts Receivable of -$11.62 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$1.97M.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$9.64M.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $6.15M, a 34.12% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $587.00K, a 90.61% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$368.00K, a 106.78% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2024 was $5.43M, a 25.97% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2023 was $7.33M, a 62.86% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2022 was $19.74M, a 59.65% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$11.62M 10-Q · filed 2026-08-05 | -$5.47M derived: sum of 3 quarters · filed 2026-08-05 | -$4.88M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$9.64M 10-Q · filed 2026-05-07 | -$3.50M derived: sum of 2 quarters · filed 2026-05-07 | -$2.91M derived: sum of 3 quarters · filed 2026-05-07 | -$3.56M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $6.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.73M derived: sum of 2 quarters · filed 2026-02-26 | $6.08M derived: sum of 3 quarters · filed 2026-08-05 | -$368.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $587.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$65.00K derived: sum of 2 quarters · filed 2026-08-05 | -$6.51M 10-Q · filed 2025-11-05 | $2.81M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | -$652.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$7.10M 10-Q · filed 2026-08-05 | $2.23M derived: sum of 3 quarters · filed 2026-08-05 | $8.48M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$6.45M 10-Q · filed 2026-05-07 | $2.88M derived: sum of 2 quarters · filed 2026-05-07 | $9.13M derived: sum of 3 quarters · filed 2026-05-07 | $3.21M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.58M derived: sum of 2 quarters · filed 2026-02-26 | $9.66M derived: sum of 3 quarters · filed 2026-02-26 | $5.43M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $6.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $334.00K derived: sum of 2 quarters · filed 2025-11-05 | -$3.90M 10-Q · filed 2025-11-05 | -$4.16M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$5.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$10.15M 10-Q · filed 2025-08-06 | -$10.42M derived: sum of 3 quarters · filed 2026-02-26 | -$3.57M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$4.24M 10-Q · filed 2025-05-08 | -$4.50M derived: sum of 2 quarters · filed 2026-02-26 | $2.35M derived: sum of 3 quarters · filed 2026-02-26 | $9.15M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.59M derived: sum of 2 quarters · filed 2026-02-26 | $13.39M derived: sum of 3 quarters · filed 2026-02-26 | $7.33M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $6.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $13.65M derived: sum of 2 quarters · filed 2024-11-07 | $7.59M 10-Q · filed 2024-11-07 | $15.56M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $745.00K 10-Q · filed 2024-08-06 | $8.71M derived: sum of 3 quarters · filed 2025-02-28 | $12.53M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | -$6.05M 10-Q · filed 2024-05-08 | $1.91M derived: sum of 2 quarters · filed 2025-02-28 | $5.72M derived: sum of 3 quarters · filed 2025-02-28 | $12.65M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $7.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $11.78M derived: sum of 2 quarters · filed 2025-02-28 | $18.71M derived: sum of 3 quarters · filed 2025-02-28 | $19.74M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $10.74M derived: sum of 2 quarters · filed 2023-11-14 | $11.78M 10-Q · filed 2023-11-14 | $12.50M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-06-30 | $6.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $7.96M 10-Q · filed 2023-08-08 | $8.68M derived: sum of 3 quarters · filed 2024-03-13 | $14.28M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-03-31 | $1.04M 10-Q · filed 2023-05-09 | $1.76M derived: sum of 2 quarters · filed 2024-03-13 | $7.35M derived: sum of 3 quarters · filed 2024-03-13 | $15.64M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2021-12-31 | $720.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $6.31M derived: sum of 2 quarters · filed 2024-03-13 | $14.60M derived: sum of 3 quarters · filed 2024-03-13 | $12.37M 10-K · filed 2024-03-13 | |
| 2021-09-30 | $5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $13.88M derived: sum of 2 quarters · filed 2022-11-09 | $11.65M 10-Q · filed 2022-11-09 | $10.50M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $8.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $6.05M 10-Q · filed 2022-08-10 | $4.91M derived: sum of 3 quarters · filed 2023-03-01 | $9.81M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | -$2.24M 10-Q · filed 2022-05-12 | -$3.38M derived: sum of 2 quarters · filed 2023-03-01 | $1.52M derived: sum of 3 quarters · filed 2023-03-01 | ||
| 2020-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.76M derived: sum of 2 quarters · filed 2023-03-01 | -$334.00K 10-K · filed 2023-03-01 | $334.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $4.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $814.00K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$4.09M 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |